Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/28/2025

Haloperidol and Lorazepam Combination for Agitation Management

Evidence for Combination Therapy

  • The American Academy of Emergency Medicine recommends the combination of haloperidol and lorazepam as an effective approach for managing acute agitation in emergency settings 1
  • The American Academy of Pediatrics mentions the haloperidol-lorazepam combination as an appropriate treatment option for agitated patients 2

Dosing Considerations

  • Typical dosing for adults includes haloperidol 2-5 mg and lorazepam 1-2 mg, which can be administered in the same syringe when given parenterally 2, 3
  • Lower doses should be used in older or frail patients, such as haloperidol 0.25-0.5 mg 3

Advantages of Combination Therapy

  • The combination of haloperidol and lorazepam has complementary mechanisms of action, providing antipsychotic and anxiolytic effects 1
  • This combination is effective for both psychiatric and medical causes of agitation 4

Potential Side Effects and Monitoring

  • Patients receiving this combination should be monitored for respiratory depression, extrapyramidal symptoms, QTc prolongation, and excessive sedation 2, 3
  • Close clinical observation, including cardiorespiratory monitoring, is necessary for patients receiving this combination 2

Special Considerations

  • The American Academy of Oncology recommends avoiding haloperidol in patients with Parkinson's disease or Lewy body dementia due to the risk of extrapyramidal side effects 3
  • In older patients, reduced doses of both medications should be used to minimize adverse effects 2, 3